NASDAQ:BIOL - Nasdaq - US0909117022 - Common Stock - Currency: USD
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the second quarter of 2024.Biol...
BIOL stock results show that Biolase missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the first quarter of 2024.Biola...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the fourth quarter of 2023.Biol...
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!
BIOL stock results show that Biolase missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
BIOLASE has been granted an extension by Nasdaq to regain compliance with Listing Rule 5550(b), which requires certain financial criteria to be met.